Back  |   PharmaSentry Homepage

  • Article Summary
  • FDA OKs Abbott's new diabetes testing strips
    From Associated Press 24-Jun-2010
    The Food and Drug Administration approved the products to test for levels of glucose, a type of blood sugar, in patients with diabetes. People with the disease have trouble breaking down carbohydrates because their bodies have become resistant to a protein used in metabolism. Abbott said the new strips contain an enzyme designed to minimize interference with test results.

    Key Concepts
    Abbott
    blood sugar
    strips
    Drug
    levels of glucose
    afternoon trading
    regulatory approval
    cents
    interference
    metabolism
    carbohydrates
    Summary
    ALAMEDA, Calif. -- Drug and device maker Abbott Laboratories said Thursday it received U.S. regulatory approval for its Freestyle blood sugar testing strips.
    The Food and Drug Administration approved the products to test for levels of glucose, a type of blood sugar, in patients with diabetes.
    People with the disease have trouble breaking down carbohydrates because their bodies have become resistant to a protein used in metabolism.
    Abbott said the new strips contain an enzyme designed to minimize interference with test results.
    North Chicago-headquartered Abbott said it would begin shipping test strips in August.
    Shares of Abbott rose 16 cents to $47.72 in afternoon trading.